Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus
SHELTON, CT / ACCESSWIRE / May 20, 2020 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development...